Health Care Sector Update For 12/17/2014: Vrml,aspx,pozn –

Health Net Issues 2015 Earnings Guidance – Yahoo Finance

In company news, shares of Vermillion Inc. ( VRML ) were in the red Wednesday after the biotech company developing prospective treatments for gynecologic disease late yesterday said it was promoting Chief Operating Officer Valerie Palmieri to president and CEO, effective with the start of the new year. Current CEO and board chairman James LaFrance will continue to serve as chairman following the upcoming change-over. Although Palmieri has only been chief operating officer at VRML since October, she was a strategic consultant with the company during the prior six months. She previously was CEO at two health care startups as well as senior positions at Dianon Systems and later LabCorp after Dianon’s acquisition. Another VRML board member, Eric Varma, said LaFrance and Palmieri have worked closely together since late April when LaFrance agreed to take on CEO responsibilities after then-Chief Executive Thomas McLain left the company, “rebuilding the Vermillion team and re-setting its strategy and creating a five year operating plan that will position the company to be a leader in the bio-analytics field.” VRML shares were down nearly 3% in late trade at $1.39 a share, just 2 cents above its session low. The stock has traded within a 52-week range of $1.20 to $3.83 a share, dropping more than 40% over the past year prior to today’s decline. In other sector news, (+) ASPX, Reports positive topline results from Phase III testing of its SD-809 drug candidate for chorea associated with Huntington’s disease. It also expects to report results from testing as treatment for tardive dyskinesia and Tourette syndrome by mid-2015.

The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the companys stock price, corporate and regulatory requirements, restrictions under the companys debt obligations, and other market and economic conditions. The share repurchase program may be suspended or discontinued at any time. The company intends to report on its repurchase activity in its quarterly financial disclosures. About Health Net Health Net, Inc. is a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Its mission is to help people be healthy, secure and comfortable. Health Net provides and administers health benefits to approximately 5.9million individuals across the country through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as Part D), Medicaid, U.S. Department of Defense, including TRICARE, and Veterans Affairs programs. Health Net also offers behavioral health, substance abuse and employee assistance programs, managed health care products related to prescription drugs, managed health care product coordination for multi-region employers, and administrative services for medical groups and self-funded benefits programs. For more information on Health Net, Inc., please visit Health Nets website at . Cautionary Statements The company and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act (PSLRA) of 1995, including statements in this and other press releases, in presentations, filings with the Securities and Exchange Commission (SEC), reports to stockholders and in meetings with investors and analysts.
Health Net Issues 2015 Earnings Guidance – Yahoo Finance


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s